ProfileGDS4718 / 1561550_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 6% 9% 8% 7% 4% 4% 5% 8% 8% 13% 4% 3% 3% 3% 5% 10% 6% 3% 3% 6% 5% 6% 6% 9% 9% 7% 10% 1% 5% 4% 3% 7% 9% 7% 3% 3% 6% 5% 5% 4% 7% 3% 2% 3% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.645716
GSM549102patient 115, normal, homogenized [OPG study]3.764619
GSM549104patient 119, normal, homogenized [OPG study]3.670138
GSM549108patient 138, normal, homogenized [OPG study]3.690787
GSM549119patient 077, normal, homogenized [OPG study]3.545984
GSM549133patient 032, cancer, homogenized [OPG study]3.512574
GSM549139patient 042, cancer, homogenized [OPG study]3.573635
GSM549099patient 107, normal, homogenized [OPG study]3.696638
GSM549109patient 139, normal, homogenized [OPG study]3.731538
GSM549110patient 046, normal, homogenized [OPG study]3.8828613
GSM549114patient 063, normal, homogenized [OPG study]3.533694
GSM549122patient 082, normal, homogenized [OPG study]3.522133
GSM549134patient 033, cancer, homogenized [OPG study]3.479153
GSM549136patient 036, cancer, homogenized [OPG study]3.454873
GSM549140patient 044, cancer, homogenized [OPG study]3.557095
GSM549111patient 047, normal, homogenized [OPG study]3.7724410
GSM549113patient 057, normal, homogenized [OPG study]3.592586
GSM549132patient 031, cancer, homogenized [OPG study]3.486223
GSM549137patient 038, cancer, homogenized [OPG study]3.488333
GSM549142patient 047, cancer, homogenized [OPG study]3.676136
GSM549100patient 110, normal, homogenized [OPG study]3.583835
GSM549107patient 135, normal, homogenized [OPG study]3.589176
GSM549115patient 068, normal, homogenized [OPG study]3.596816
GSM549116patient 072, normal, homogenized [OPG study]3.735589
GSM549120patient 078, normal, homogenized [OPG study]3.747129
GSM549131patient 030, cancer, homogenized [OPG study]3.639547
GSM549118patient 074, normal, homogenized [OPG study]3.7752910
GSM549129patient 027, cancer, homogenized [OPG study]3.379461
GSM549123patient 088, normal, homogenized [OPG study]3.600165
GSM549124patient 006, cancer, homogenized [OPG study]3.575584
GSM549126patient 015, cancer, homogenized [OPG study]3.469023
GSM549128patient 025, cancer, homogenized [OPG study]3.646157
GSM549103patient 117, normal, homogenized [OPG study]3.765399
GSM549117patient 073, normal, homogenized [OPG study]3.669027
GSM549138patient 041, cancer, homogenized [OPG study]3.478993
GSM549141patient 045, cancer, homogenized [OPG study]3.45353
GSM549130patient 028, cancer, homogenized [OPG study]3.614366
GSM549101patient 111, normal, homogenized [OPG study]3.5755
GSM549105patient 128, normal, homogenized [OPG study]3.610835
GSM549106patient 134, normal, homogenized [OPG study]3.520454
GSM549112patient 048, normal, homogenized [OPG study]3.651577
GSM549125patient 011, cancer, homogenized [OPG study]3.477273
GSM549127patient 024, cancer, homogenized [OPG study]3.391572
GSM549135patient 035, cancer, homogenized [OPG study]3.454873